After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that ...

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

All types of radiation become less intense as they travel further away from the radioactive material. This is because the particles or rays become more spread out. The thicker the substance ...

The gene expression signature PORTOS can determine which patients with localized prostate cancer will benefit ... PORTOS could be used to help guide radiation dose-escalation and de-escalation ...